JENNIFER MCREYNOLDS: Open Payments
NPI 1942224100 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,285 in 132 payments from 21 companies in 2025. Trend: 2023 $874 · 2024 $729 · 2025 $2,285
Food & beverage: $2,285
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $236 |
| Neurocrine BioSciences, Inc. | 15 | $220 |
| Axsome Therapeutics, Inc. | 15 | $220 |
| Alkermes, Inc. | 12 | $217 |
| ABBVIE INC. | 16 | $201 |
| Vanda Pharmaceuticals Inc. | 9 | $188 |
| Noven Therapeutics, LLC | 13 | $163 |
| Otsuka America Pharmaceutical, Inc. | 10 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $128 |
| Bausch Health US, LLC | 5 | $119 |
Products named: CAPLYTA, INGREZZA, FANAPT, Xelstrym, REXULTI, Auvelity, ARISTADA, TRINTELLIX.
Industry payments across OK — which companies pay providers there.
